Back

Point-of-care biomarkers of thrombotic status predict spontaneous reperfusion in ST-segment elevation MI and clinical outcomes

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Biomarkers for risk stratification in acute coronary syndromes (1) Thrombosis, Platelets, and Coagulation ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Rahim Kanji

National Heart and Lung Institute, London (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
Biomarkers for identification of high-risk coronary plaques in patients with suspected coronary artery disease
Miss G. Pedersen (Aarhus, DK)
Abstract Slides Video
Presentation thumbnail
Different diagnostic value of risk factors for ACS in relation to initial troponin level and early dynamic change
Doctor R. Alam (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
The effect of LDL-C/HDL-C ratio on severity of coronary artery disease and 2-year long-term prognosis in patients with premature coronary heart disease---a multicenter, observational results
Doctor J. Xu (Beijing, CN)
Abstract Slides
Presentation thumbnail
Circulating NETosis markers in NSTEMI and predicting of 1-year cardiac death
Doctor M. Munteanu (Chisinau, MD)
Abstract Slides Video

Access the full session

Session thumbnail
Biomarkers for risk stratification in acute coronary syndromes (1)

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Platelet-large cell ratio predicts no-reflow in patients undergoing primary coronary angioplasty for ST-segment elevation myocardial infarction
thumbnail
Congress Presentation
Thrombolysis versus primary percutaneous coronary intervention in patients with suspected ST-elevation myocardial infarction - a SWEDEHEART observational study
thumbnail
Congress Presentation
Is spontaneous pre-hospital coronary reperfusion in STEMI safe ?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources